» Articles » PMID: 11158221

Renal Interstitial Fibrosis is Reduced in Angiotensin II Type 1a Receptor-deficient Mice

Overview
Specialty Nephrology
Date 2001 Feb 7
PMID 11158221
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Unilateral ureteral obstruction (UUO) results in tubulointerstitial fibrosis of the affected kidney by stimulating the renin-angiotensin system. This study established a UUO model in angiotensin type 1a receptor (AT1a) deficient (mutant) mice to elucidate the role of angiotensin II through AT1a on the fibrosis of the obstructed kidney (OBK). The relative volume of the tubulointerstitium was measured by an image analyzer; deposition of collagen types III and IV and monocyte/macrophage infiltration were histologically examined using specific antibodies. Also determined were the mRNA levels of transforming growth factor-beta by Northern blot analysis. Nuclear factor-kappaB activity was assessed by gel shift assay. UUO in wild mice resulted in a marked expansion of relative volume of the tubulointerstitium, together with increased deposition of collagen types III and IV and number of infiltrated monocytes/macrophages in the interstitium, relative to sham-operated mice. In comparison, these changes were significantly lower in mutant mice with UUO. The mRNA level of transforming growth factor-beta was significantly higher in the OBK of wild mice with UUO compared with sham-operated mice. In contrast, the increase in mRNA level in the OBK of mutant mice was significantly less than in wild mice. Finally, UUO resulted in activation of nuclear factor-kappaB in wild mice but was inhibited in the OBK of mutant mice. The results provide direct evidence that angiotensin II acting via the AT1a plays a pivotal role in the development of tubulointerstitial fibrosis in UUO.

Citing Articles

Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs.

Gu Y, Liu X, Lan H Mol Ther. 2023; 32(2):313-324.

PMID: 38093516 PMC: 10861968. DOI: 10.1016/j.ymthe.2023.12.009.


Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis.

Norregaard R, Mutsaers H, Frokiaer J, Kwon T Physiol Rev. 2023; 103(4):2827-2872.

PMID: 37440209 PMC: 10642920. DOI: 10.1152/physrev.00027.2022.


The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney.

Higgins C, Tang J, Higgins S, Gifford C, Mian B, Jones D Front Cell Dev Biol. 2021; 9:678524.

PMID: 34277620 PMC: 8284093. DOI: 10.3389/fcell.2021.678524.


The MicroRNA MiR-29c Alleviates Renal Fibrosis via TPM1-Mediated Suppression of the Wnt/β-Catenin Pathway.

Huang H, Huang X, Luo S, Zhang H, Hu F, Chen R Front Physiol. 2020; 11:331.

PMID: 32346368 PMC: 7171049. DOI: 10.3389/fphys.2020.00331.


Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.

Mou F, Mou C Med Sci Monit. 2020; 26:e919739.

PMID: 32019905 PMC: 7020761. DOI: 10.12659/MSM.919739.